Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

ZD9331 With or Without Topotecan in Treating Patients With Refractory or Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

This study has been completed.
Information provided by:
National Cancer Institute (NCI) Identifier:
First received: April 10, 2001
Last updated: August 1, 2013
Last verified: December 2004
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2004
  Estimated Primary Completion Date: No date given